J&J Gets Ready to Break up With Tylenol
Johnson & Johnson’s consumer business was the only division to deliver growth in the fourth quarter.
- Dozens of NYSE Stocks Halted in Opening Minutes After Wild Price Swings
- The 18 Best Destinations (Plus Tips)
